Wayland Group Receives $5 million Bridge Loan From Cryptologic Corp.

August 09, 19

TORONTO, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (“Wayland”) and Cryptologic Corp. (CSE: CRY) (“Cryptologic”) are pleased to announce that Wayland has now received the previously announced $5 million bridge loan from Cryptologic, which has been advanced in connection with the proposed sale of Wayland’s Canadian business to Cryptologic. “This bridge loan will

Read More

Wayland Enters Non-Binding LOI to Sell Canadian Business to Cryptologic Corp.

August 02, 19

Obtains Commitment for Cdn$5 million Bridge Loan From Cryptologic Negotiating Second Phase of Transfer of International Business to  ICC International Cannabis Corp. Intends to Distribute Cryptologic and ICC Shares to Wayland Shareholders on Closing; Aggregate Ownership Interest of Wayland Securityholders Expected to be 70% (Cryptologic) and 60% (ICC) Matthew McLeod Appointed as Wayland CEO Through Closing

Read More

Wayland Group Announces Changes to the Board of Directors

July 08, 19

TORONTO, July 08, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced that Matthew McLeod, the Company’s President, has been appointed to the board of directors and that Gerhard Müller has resigned as a director of the Company. “We are excited to have Matthew join our board and look forward to

Read More

Wayland Group Closes Transaction with ICC International Cannabis Corp.

May 30, 19

TORONTO, May 29, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has completed a transaction relating to the sale of a 49.9% interest in Maricann B.V. (“Wayland International”), to ICC International Cannabis Corp. (CSE:WRLD.u) (FW8:8K51) (OTC:KNHBF) (“ICC”) pursuant to the terms of

Read More

Wayland Addresses Transaction with ICC International Cannabis Corp.

May 02, 19

TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) confirms that any failure-to-file cease trade order (“FFCTO”) derived from the Company’s delay in annual filings will not materially affect the Company’s sale of a 49.9% interest in its international asset and license portfolio to ICC International Cannabis

Read More

Wayland Group Confirms Delay in Annual Filings; Expects Issuance of Cease Trade Order

April 30, 19

TORONTO, ON, April 30, 2019 – Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that it will be delayed in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required Filings”)

Read More

Wayland Group Announces Anticipated Delay in Annual Filings

April 23, 19

TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that it anticipates a delay in filing its audited annual financial statements for the year ended December 31, 2018, the related management’s discussion and analysis and certificates of its CEO and CFO (collectively, the “Required

Read More

Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of International Business

April 23, 19

TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio of assets to ICC International Cannabis Corp. (CSE:WRLD.u) (FW8:8K51) (OTC:WLDCF) (“ICC”). The terms of the definitive agreement

Read More

Wayland Provides Clarification on Recent German Tender Update

April 19, 19

TORONTO, April 18, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to expand on the update that the Company provided to the market on April 17, 2019 with respect to the ongoing process for domestic cultivation of medical cannabis in Germany (“the Update”). The Company would like

Read More

Wayland Provides Update on German Tender Process

April 17, 19

TORONTO, ON, April 17, 2019 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Earlier today, the German Federal Institute for Drugs and Medical Devices (“BfArM”) announced that 9 of the 13 cultivation

Read More